medline.ch Neurologie Alzheimer

	Plasma lncRNA signature of upregulated ATP2B1-AS1 and downregulated RPL21P28 correlates with diagnosis and cognitive severity in Alzheimer's disease. Front Aging Neurosci Yadollahi Khales A, Ghaedi K, Esmaeili F, Noorbakhshnia M, Etemadifar M. PMID: 42318555 [PubMed]
	Heterogeneous trajectories of executive function in clinical Alzheimer's disease: Results from the 3C study. Alzheimers Dement (Amst) Amieva H, Dussartre M, Philipps V, Rouanet A, Dufouil C, Jacqmin-Gadda H, Dartigues JF, Pérès K, Samieri C, Catheline G, Helmer C, Proust-Lima C. PMID: 42318440 [PubMed]
	Ethanol exposure and high-fat diet: assessing the neuroimmune and metabolic mechanisms in Alzheimer's disease pathology. Front Neurosci Njoku GC, Saraswathi V. PMID: 42318197 [PubMed]
	Altered Effective Connectivity Within the Frontoparietal Network in Alzheimer's Disease and Its Modulation by Acupuncture: A Resting-State fMRI Study. Neuropsychiatr Dis Treat Wei YT, Li L, Xie WT, Wang Y, Zhao YR, Zhang RZ, Ma L, Yan XK. PMID: 42318047 [PubMed]
	Use of Artificial Intelligence for the Early Detection and Prediction of Alzheimer's Disease. Cureus Khangsar LT, Boileau AJ. PMID: 42317938 [PubMed]
	Nano-based spectroscopic approaches for early diagnosis of Alzheimer's disease: critical insights into amyloid-Î² and tau biomarker biology and detection tools. Biophys Rev Tatar AS, Colnita A, Brezestean IA, Boca S. PMID: 42317543 [PubMed]
	Spatial transcriptomics in Alzheimer's disease: technologies, challenges and discoveries. Mol Neurodegener Adv Shi CH, Piña-Crespo JC, Yip KY, Huang TY. PMID: 42317262 [PubMed]
	Neuropsychological criteria for Mild Cognitive Impairment (MCI) best identify neuroimaging-based risk profiles: A Department of Defense/Alzheimer's Disease Neuroimaging Initiative study. J Int Neuropsychol Soc Matchanova A, Ly MT, Frank C, Zaratan A, Bangen KJ, Bondi MW, Delano-Wood L, Department of Defense Alzheimer. PMID: 42316769 [PubMed - as supplied by publisher]
	Impact of sex differences on microglial function in Alzheimer's disease. Alzheimers Res Ther Figueiredo EV, Azevedo CV, Penitente AR, Pedrosa VR, Camilo da Silva VR, Longo BM. PMID: 42316324 [PubMed - as supplied by publisher]
	Associations of plasma biomarkers of Alzheimer's disease pathology with modifiable risk factors and cognitive and functional outcomes: evidence from cross-sectional prediction and latent path analyses in the Bio-Hermes-001 cohort. Alzheimers Res Ther Kirk M, Kwon J, Mavromati K, Gordon-Boyle A, Bhui K, Koychev I, Bauermeister S, Tsiachristas A. PMID: 42316310 [PubMed - as supplied by publisher]
	Nanoparticles that target nonamyloid and nontau pathways in Alzheimer's disease. Discov Nano Alavian F, Hajimohammadi A. PMID: 42315809 [PubMed]
	Association of Cathepsin Proteins with Alzheimer's Disease Risk: An Integrated Observational and Genetic Analysis. Neuromolecular Med Zhang Q, Li Q, Ai Z, Li F, Wang Y, Zhou W. PMID: 42315799 [PubMed - indexed for MEDLINE]
	Cannabinoids Treatment for Agitation in Alzheimer's Disease: A Systematic Review and Meta-Analysis With Bayesian and Sequential Trial Analyses. Am J Geriatr Psychiatry da Silva AMP, de Siqueira Lima DV Jr, Figueiroa Souza R, Lopes VHP, Januario Campos Cardoso L, Ornelas Pinto EL, Gonçalves OR, Braga C, Cal H, Haddad DS, Vasconcelos SMM, Duarte FS, Perry G, Anghinah R. PMID: 42315374 [PubMed - as supplied by publisher]
	Fluorescence Lifetime and Smartphone-Enabled Detection of Amyloid-Î² for Diagnosis and Staging in Alzheimer's Disease. ACS Chem Neurosci Bhagavath KK, Ramesh M, Kumar Y, Mandal S, Ila H, Govindaraju T. PMID: 42314111 [PubMed - as supplied by publisher]
	Clinical Evaluation of the Revised Biological and Clinical Staging Criteria for Alzheimer Disease in China. Neurology Wang ZY, Xin JW, Wang MY, Chen S, Chen K, Lu J, Huang YY, Zhang W, Huang W, Wang R, Xie F, Cheng W, Chen X, Zuo C, Cui M, Zhao Q, Yu JT. PMID: 42314105 [PubMed - indexed for MEDLINE]
	Phase 2 Futility Trials in Alzheimer Disease and Mild Cognitive Impairment: A Cohort Analysis of the ADNI Data Set. Neurology Ganesh A, Smith EE, Mostert J, Strijbis EM, Schoonheim MM, Xia C, Nadeau Y, Leavitt VM, Kalia LV, Engelborghs S, D'Haeseleer M, McPherson T, Cutter GR, Koch MW, for Alzheimer's Disease Neuroimaging Initiative (ADNI). PMID: 42314102 [PubMed - indexed for MEDLINE]
	Status of Alzheimer's and Parkinson's Disease Detections and Treatments. ACS Chem Neurosci Nguyen PH, Derreumaux P. PMID: 42313891 [PubMed - as supplied by publisher]
	Targeting brain rhythms to support cognition in aging: a systematic review and meta-analysis of tACS across healthy aging, mild cognitive impairment, and Alzheimer's disease. Geroscience Freitas da Costa B, Reuwsaat K, Emele N, Carvalho CM, Caparelli-Dáquer E, Panizzutti R. PMID: 42313252 [PubMed - as supplied by publisher]
	Radiomics-enhanced (18)F-AV45 PET/MRI for integrative assessment and centiloid estimation of amyloid-Î² burden in Alzheimer's disease. Eur Radiol Exp Yuan Z, Zhang J, Zhou Z, Chen X, Qi N, Wang W, Cheng X, Lin Y, Zhao J. PMID: 42313223 [PubMed - indexed for MEDLINE]
	Alzheimer's Disease and MERC Dysfunction: Integrating Mechanisms, Biomarkers, and Therapeutic Strategies. Mol Neurobiol Kashif M, Majumder D. PMID: 42313219 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 70936

Seite 1 von 3547

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung